Stroke Prevention in Atrial Fibrillation

Why is this important?

This module, Stroke Prevention in Atrial Fibrillation, addresses three primary strategies for reducing stroke: (1) diagnosis of atrial fibrillation (AF), (2) AF anticoagulation therapy, and (3) referral of complex AF patients for consultation with a cardiologist or electrophysiologist when it is clear that desired patient outcomes are not being met with prescribed therapy.

  • Stroke is the leading preventable cause of disability in the United States.
  • Stroke risk persists in patients with atrial fibrillation regardless of symptoms and/or rhythm management.
  • Significant gaps exist in treating atrial fibrillation for the prevention of stroke.
  • Anticoagulation can reduce the risk of stroke by 60 to 80 percent.
  • Up to two-thirds of AF patients who had strokes were not prescribed anticoagulants or blood thinners.

How will these tools help?

  • The tools may increase the comfort level of primary care physicians initiating anticoagulation.
  • The tools help clinicians consider anticoagulation sooner in patients who are found to have atrial fibrillation with at least one risk factor for stroke.
  • The tools help clinicians consider referral to cardiologist or electrophysiologist when it is clear that desired patient outcomes (rate, rhythm or symptom control) are not being met with prescribed therapy.


 

Target Audience

Target Audience

  • Physicians

  • Physician Assistants

  • Nurse Practitioners

  • Registered Nurses

  • Medical Assistants

  • Practice Managers

Learning Objectives

Learning Objectives

  • Recognize atrial fibrillation in patients not yet diagnosed with the disorder, including those with comorbidities such as sleep apnea and thyroid disorders
  • Apply the CHADS2; CHA2DS2-VASC; and HAS-BLED risk scoring systems to determine appropriate anticoagulation therapy based upon individual risk of stroke and bleeding
  • Effectively communicate with patients regarding the pros and cons of different anticoagulation strategies; the risk of stroke and bleeding; and the importance of lifelong adherence to the prescribed therapy
  • Refer appropriate patients to a cardiologist or electrophysiologist for consultation as soon as it is clear that desired patient outcomes for rate or rhythm control, symptom relief or stroke risk reduction are not being met with prescribed therapy.

 

 

Grant funding for this module was provided by Bristol-Myers Squibb

Course summary
Available credit: 
  • 20.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 20.00 ABIM MOC
  • 20.00 ABMS MOC
Course opens: 
06/29/2017
Course expires: 
06/29/2020
Cost:
$0.00
Parent activity set: 
Rating: 
0

Stroke Prevention in Atrial Fibrillation CME Information and Disclosures

Practice Advisor Content Manager: 

Jillian Schneider, MHA

Manager Practice Support, American College of Physicians

 

Contributors:

 

Andrew Dunn, MD, MPH, SFHM, FACP

Professor of Medicine

Chief, Division of Hospital Medicine

Mount Sinai Health System

 

Marcin Kowalski, MD, MBA, FACC, FHRS

Director of Cardiac Electrophysiology

Associate Director of Cardiology Fellowship Program

Staten Island University Hospital, Northwell Health System

 

Tara Parham, MSN, CRNP

Acute Care Nurse Practitioner, Cardiac Electrophysiology

Hospital of the University of Pennsylvania

 

Staff Editors:

 

Laura Blum Meisnere

Vice-President, Health Policy

 

Andrea Brock, JD

Senior Associate, Grants Acquisition, American College of Physicians

 

Michele Duchin-Watson

Associate, Center for Quality, American College of Physicians

 

Jillian Nash-Arot

Associate, Center for Patient Partnership in Healthcare, American College of Physicians

 

Wendy Nickel, MPH

Director Center for Patient Partnership, American College of Physicians

 

 

Anne Marie Smith, MBA

Vice-President, Quality Improvement Education

 

Selam Wubu, MPH

Senior Associate, Center for Quality, American College of Physicians

 

CME/MOC Credit

*To earn CME credit, you must attest after completion of the second module biopsy that you have:

  • participated in the completion of the ACP Practice Biopsy
  • participated in the review of the ACP Practice Biopsy results
  • participated in identifying an action plan to improve our practice
  • participated in the implementation of the plan
  • participated in the follow-up ACP Practice Biopsy to measure improvement

When you have done so, follow the on-screen instructions to complete and submit the submission form. You will receive confirmation of your submission available as a PDF certificate and via email.

The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Physicians designates this PI CME activity, ACP Practice Advisor® module Stroke Prevention in Atrial Fibrillation, for a maximum of 20 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Practice Assessment points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.  It is the CME activity provider's responsibility to submit participant completion information for the purpose of granting ABIM MOC credit.

Available Credit

  • 20.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 20.00 ABIM MOC
  • 20.00 ABMS MOC

Accreditation Period

Course opens: 
06/29/2017
Course expires: 
06/29/2020

Price

Cost:
$0.00
Please login or register to take this course.